iChoose Kidney vs ALGO+

The iCHOOSE mobile application and corresponding website is expected to serve as a decision support tool for nephrologists, primary care physicians, social workers, nurses, and/or patient educators to use with ESRD patients to help improve informed decision making for kidney failure treatment options. Risk prediction models for mortality on dialysis of kidney transplantation are presented.

ALGO+ is an innovative patient management application for doctors to enable, integrate and digitalize the management of patients for clinical research. It modernizes patient-doctor partnerships in medical care by connecting patients directly with doctors and nurses on a single platform. Unified Platform: Doctors are provided with an easy-to-use tool to efficiently manage patient accounts, research activities and communications. Patients are able to effortlessly participate in the research remotely and interact with the doctors on treatment, medical care and follow-ups. Patient-Centered: ALGO+ app supports value-based healthcare and fit-for-purpose research by enabling high-quality care, positive patient experience and good health outcomes right from the onset. Quality Management: Routine clinic processes are being simplified and made operationally feasible for monitoring of patients and oversight of the research to ensure safety and data integrity. ALGO+ is a Good Clinical Practice (GCP), 21 CFR Part 11, privacy and security compliant app